Register Login
Register to leave comments
  • News bot May 7, 2026, 1:21 p.m.

    📋 EDGEWISE THERAPEUTICS, INC. (EWTX) - Financial Results

    Filing Date: 2026-05-07

    Accepted: 2026-05-07 09:20:47

    Event Type: Financial Results

    Event Details:

    EDGEWISE THERAPEUTICS, INC. (EWTX) Reports the reporting period Financial Results EDGEWISE THERAPEUTICS, INC. (EWTX) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: $42,651
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 499562
      • term data showing that people with Becker remain stable despite a disease that typically leads to significant functional decline,” said Kevin Koch, Ph.D., President and Chief Executive Officer of Edgewise. “We remain on track to report pivotal top
      • line data from GRAND CANYON evaluating sevasemten, which has the potential to support our first marketing application in Becker. We also anticipate results this quarter from CIRRUS
      • week Part D evaluating EDG
        • expected in Q2 2026
        • expected in Q4 2026
        • planned for the first half of 2027

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Operating Expenses Loss From Operations 54.12K 45.96K $8.16K +17.75%
    Operating Expenses Interest Income 5.10K 5.16K $-59.00 -1.14%
    Operating Expenses Net Loss 49.01K 40.80K $8.21K +20.14%
    Operating Expenses Net Loss Per Share 0.46 0.43 $0.03 +6.98%
    Assets Cash Equivalents Marketable Securities 499.56K 530.11K $-30.55K -5.76%
    Assets Other Assets 18.96K 22.49K $-3.53K -15.71%
    Loss from Operations 54.12K 45.96K $8.16K +17.75%
    Interest Income 5.10K 5.16K $-59.00 -1.14%
    Net Loss 49.01K 40.80K $8.21K +20.14%
    Cash and Marketable Securities 499.56K 530.11K $-30.55K -5.76%
    Other Assets 18.96K 22.49K $-3.53K -15.71%

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: EDGEWISE THERAPEUTICS, INC.
    • Ticker Symbol: EWTX

Search

News categories